Skip to main content

Remember me

+34 935 481 848

Home
- Kymos
- Pharmaprogress
About us
Sectors
Services
Press Room
- Blog
- Newsletter
Work with us
Contact

Newsletter

You are here:
Home/
Press Room/
Newsletter

2019

in vitro release test and in vitro permeation test

Quality & Equivalence of Topical Drug Products

New Generation Cascade Impactor

Orally Inhaled and Nasal Drug Product Testing

Electrophoresis instruments

Electrophoresis in QC of biologics

2018

Microbiology plate

In-Use Microbial Stability

Kymos. Elemental impurities in purified water

Elemental Impurities in Purified Water

Heparin testing

Heparin Testing

Percutaneous absorption

Bioequivalence of Topical Products

Vaccine potency assay

Vaccine potency assay

Fit-to-Purpose Bioanalytical Methods

Stability studies

Stability Studies

2017

GC-MS

Extractables & Leachables

Skin

Percutaneous Absorption

ICH Q3D compliance

ICH Q3D Compliance

TOC Analysis

TOC Analysis

Biomarkers and Immunogenicity

Biomarkers and Immunogenicity

ICP-MS

Elemental impurities determination by ICP-MS

Subscribe to newsletter

I have read the Privacy Policy *

GO TO CATALOGS

Scroll

Your reliable partner for Research and Development

Meet us

Nordic Life Science Days. 10-12 September. Malmö-Copenhagen

Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress. Rome. Italy. 19-18 October 2019

CPhI Worldwide. Frankfurt. 5-7 November 2019

European Bioanalysis Forum. Barcelona. 20-22 November 2019

Policy of Cookies

Contact Info

KYMOS PHARMA SERVICES, S.L.

Parc Tecnològic del Vallès. Ronda Can Fatjó, 7B. 08290 Cerdanyola del Vallès. Barcelona. SPAIN

VAT: B-62170337

+34 935 481 848

Map